Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06861907 · ClinicalTrials.gov registry record

IMPRINT VR Trainer Evaluation

A clinical trial of Virtual Reality, sponsored by Charles River Analytics.

Completed
Registry status
4
Enrollment target
1
Study location

NCT06861907: Completed study of Virtual Reality, sponsored by Charles River Analytics.

NCT06861907 is a study of Virtual Reality that has completed, run by Charles River Analytics. The registered enrollment target is 4 participants, below the 92-participant average among 19 other Virtual Reality trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06861907, a study of Virtual Reality, has completed, sponsored by Charles River Analytics.

COMPLETED
Registry status
4 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess whether the Immersive Modular Preparedness Intelligent Tutor (IMPRINT) virtual reality (VR) training modules provide a measurable benefit in training delivery and trainee engagement. Specifically, the investigators want to see how VR can enhance trainees' comprehension and retention of key HAZWOPER concepts, and how it supports you as trainers in presenting these materials more effectively.

Primary Outcome

SUS measures the usability of a system or interface. Higher scores on SUS indicate better usability. Typically, SUS scores are standardized to a scale of 0 to 100, where a score above 68 is considered above average usability, and scores above 80 indicate excellent usability

Conditions Studied

Interventions

  • DEVICE Virtual Reality

Study Locations (1)

Massachusetts

  • The New England Consortium - Lowell

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2024-10-08
Est. Completion 2024-10-30
Charles River Analytics

1 total trials

What the finished NCT06861907 record still lists

NCT06861907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 92-participant average among 19 other Virtual Reality trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Virtual Reality appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality is the first listed.

NCT06861907 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06861907 about?

NCT06861907 is a clinical study titled "IMPRINT VR Trainer Evaluation". The goal of this study is to assess whether the Immersive Modular Preparedness Intelligent Tutor (IMPRINT) virtual reality (VR) training modules provide a measurable benefit in training delivery and trainee engagement. Specifically, the investigators want to see how VR can enhance trainees' comprehe...

What is the current status of trial NCT06861907?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2024-10-08. Estimated completion is 2024-10-30.

What conditions does trial NCT06861907 study?

This clinical trial studies the following conditions: Virtual Reality.

What interventions are being tested in trial NCT06861907?

The interventions under investigation include: Virtual Reality (DEVICE).

Who is sponsoring clinical trial NCT06861907?

This trial is sponsored by Charles River Analytics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06861907 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Virtual Reality

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06861907's enrollment target sits among peer trials

4 20th of 19 the lowest of 19 other Virtual Reality trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Virtual Reality trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06861907, the US trial registry maintained by the National Library of Medicine. NCT06861907 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.